These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1009896)

  • 1. Biological activities of tyrosine-containing somatostatin analogs on inhibition of secretion of thyrotropin and growth hormone.
    Ohashi S; Sawano S; Kokubu T; Gondo M; Sakakibara K
    Endocrinol Jpn; 1976 Oct; 23(5):435-8. PubMed ID: 1009896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variety of GH and TSH responses to somatostatin in perfused rat pituitaries in vitro.
    Sawano S; Kokubu T; Ohashi S
    Endocrinol Jpn; 1976 Dec; 23(6):541-5. PubMed ID: 1022527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosylated analogues of somatostatin.
    Rivier JE; Brown MR; Vale WW
    J Med Chem; 1976 Aug; 19(8):1010-3. PubMed ID: 966246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superactive octapeptide somatostatin analogs containing tryptophan at position 1.
    Cai RZ; Karashima T; Guoth J; Szoke B; Olsen D; Schally AV
    Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2502-6. PubMed ID: 2882520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octapeptide analogs of somatostatin exhibiting greatly enhanced in vivo and in vitro inhibition of growth hormone secretion in the rat.
    Murphy WA; Heiman ML; Lance VA; Mezo I; Coy DH
    Biochem Biophys Res Commun; 1985 Nov; 132(3):922-8. PubMed ID: 2866766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of somatostatin receptors controlling growth hormone and thyrotropin secretion in the chicken using receptor subtype-specific agonists.
    Geris KL; de Groef B; Rohrer SP; Geelissen S; Kühn ER; Darras VM
    J Endocrinol; 2003 May; 177(2):279-86. PubMed ID: 12740016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel heptapeptide somatostatin analog displays anti-tumor activity independent of effects on growth hormone secretion.
    Murphy WA; Taylor JE; Moreau JP; Coy DH
    Pept Res; 1989; 2(1):128-32. PubMed ID: 2577697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological activity of highly potent heptapeptide analogs of somatostatin with C-terminal modifications.
    Janecka A; Zubrzycka M
    Endocr Regul; 2001 Jun; 35(2):75-9. PubMed ID: 11563935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of highly potent octapeptide analogs of somatostatin.
    Cai RZ; Szoke B; Lu R; Fu D; Redding TW; Schally AV
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1896-900. PubMed ID: 2869490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activity of somatostatin and somatostatin analogs on inhibtion of arginine-induced insulin and glucagon release in the rat.
    Brown M; Rivier J; Vale W
    Endocrinology; 1976 Feb; 98(2):336-43. PubMed ID: 813991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of somatostatin on thyrotropin, prolactin, growth hormone and insulin responses to thyrotropin releasing hormone and arginine in healthy, hypothyroid and acromegalic subjects.
    Faure N; Dussault JH; Nadeau A; Szots F; Guyda H; Labrie F
    Can Med Assoc J; 1977 Sep; 117(5):478-81. PubMed ID: 409475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of hypothalamic regulatory peptides.
    Vale W; Rivier C; Brown M; Leppaluoto J; Ling N; Monahan M; Rivier J
    Clin Endocrinol (Oxf); 1976; 5 Suppl():261S-273S. PubMed ID: 829923
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release.
    Karashima T; Cai RZ; Schally AV
    Life Sci; 1987 Aug; 41(8):1011-9. PubMed ID: 2886886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin receptors on pituitary somatotrophs, thyrotrophs, and lactotrophs: pharmacological evidence for loose coupling to adenylate cyclase.
    Epelbaum J; Enjalbert A; Krantic S; Musset F; Bertrand P; Rasolonjanahary R; Shu C; Kordon C
    Endocrinology; 1987 Dec; 121(6):2177-85. PubMed ID: 2890515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel somatostatin analogs with tyrosine kinase inhibitory and antitumor activity.
    Kéri G; Mezö I; Horváth A; Vadász Z; Balogh A; Idei M; Vántus T; Teplán I; Mák M; Horváth J
    Biochem Biophys Res Commun; 1993 Mar; 191(2):681-7. PubMed ID: 8096383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent, highly selective inhibition of growth hormone secretion by position 4 somatostatin analogs.
    Murphy WA; Meyers CA; Coy DH
    Endocrinology; 1981 Aug; 109(2):491-5. PubMed ID: 6113951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of somatostatin (growth hormone inhibiting factor: GIF) on TRH-induced TSH release in rats.
    Utsumi M; Makimura H; Yamada A; Tateiwa M; Mori H; Kusaka T; Sakoda M; Baba S
    Endocrinol Jpn; 1974 Oct; 21(5):449-52. PubMed ID: 4217275
    [No Abstract]   [Full Text] [Related]  

  • 18. Somatostatin: analogs with selected biological activities.
    Brown M; Rivier J; Vale W
    Science; 1977 Jun; 196(4297):1467-9. PubMed ID: 867045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release.
    Meyers C; Arimura A; Gordin A; Fernandez-Durango R; Coy DH; Schally AV; Drouin J; Ferland L; Beaulieu M; Labrie F
    Biochem Biophys Res Commun; 1977 Jan; 74(2):630-6. PubMed ID: 836315
    [No Abstract]   [Full Text] [Related]  

  • 20. Growth hormone release in the rat: effects of somatostatin and thyrotropin-releasing factor.
    Brown M; Vale W
    Endocrinology; 1975 Nov; 97(5):1151-6. PubMed ID: 810343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.